Clinical trial
Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication…
NCT00436787 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00436787 |
|---|---|
| Title | Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers |
| Official title | Pharmacokinetic Properties of Fondaparinux Sodium in Morbidly Obese Volunteers |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Venous Thrombosis, Pulmonary Embolism |
| Intervention type | Drug |
| Interventions | Fondaparinux Sodium |
| Enrollment | 21 |
| Start date | Feb 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Feb 19, 2007 |
| Last update posted | May 16, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: